Consistent with the role of PPARγ in glucose and lipid homeostasis, an abnormal activity of PPARγ is often associated with the development of metabolic disorders (e.g., obesity, type 2 diabetes, and fatty liver disease) [5]. The gene discussed is PPARG; the disease is metabolic disease.